Stay updated on Pediatric Tolerability of Xerecept in Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tolerability of Xerecept in Clinical Trial page.

Latest updates to the Pediatric Tolerability of Xerecept in Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAn addition of Revision: v3.4.2 is displayed. The notice about government funding lapse and the reference to Revision: v3.4.1 have been removed.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a government funding lapse notice banner and updated the site revision to v3.4.1, replacing the previous v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedA glossary toggle was added and footer notes were updated to include No FEAR Act Data and Revision: v3.4.0, with minor wording changes (e.g., capitalization in 'Last Update Submitted that Met QC Criteria'). The study content remains unchanged.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; no study content or page functionality were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA consolidated Locations section now lists Illinois and Massachusetts as study sites, replacing separate 'Illinois Locations' and 'Massachusetts Locations' entries. The HHS Vulnerability Disclosure link was removed and the revision updated to v3.3.3.SummaryDifference0.4%

- Check92 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Pediatric Tolerability of Xerecept in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tolerability of Xerecept in Clinical Trial page.